Tempus, UPenn Team Up to Improve Leukemia Treatment

News   Apr 28, 2017 | Original story from Tempus

 
Tempus, UPenn Team Up to Improve Leukemia Treatment
 
 
 

RELATED ARTICLES

The Resilience of the Down's Syndrome Genome

News

People with Down's Syndrome have a genome optimised against rare mutation and a well-balanced gene expression rate, a study suggests.

READ MORE

Cancer Stem Cell Survival is Controlled by Hedgehog Signaling Proteins

News

Research reveals that cancer stem cell survival is controlled by a specific feature of the Hedgehog signaling pathway (SHH-PTCH1), which allows cells to respond to external signals in addition to inhibiting stem cell differentiation.

READ MORE

Synthetic Horsepox Virus Could Lead to More Effective Smallpox Vaccine

News

University of Alberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE